For patients with pathologically confirmed CRC, CEA is produced by the primary tumor and released into the bloodstream, which then induces the production of proangiogenic factors in the liver tissue, affects the biological behaviors of proangiogenic endothelial cells, and participates in signal transduction in endothelial cells. This evidence concerns the gene CEACAM5 and colorectal carcinoma.